NCT01466270View on ClinicalTrials.gov

Study of Donepezil in Female Breast Cancer Survivors With Cognitive Dysfunction

PHASE2CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

October 1, 2013

Study Completion Date

October 1, 2013

Conditions
Anxiety DisorderBreast CancerCognition DisordersDepressionFatigueSleep Disorders
Interventions
DRUG

donepezil hydrochloride

Given PO

DRUG

Placebo

Given PO

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Wake Forest University Health Sciences

OTHER

NCT01466270 - Study of Donepezil in Female Breast Cancer Survivors With Cognitive Dysfunction | Biotech Hunter | Biotech Hunter